LMG Life Sciences Recognizes Wolf Greenfield in 2018 Edition
2 min read
The 2018 edition of LMG Life Sciences highly recommended Wolf Greenfield for patent prosecution as well as patent strategy and management, and named six of its attorneys “Life Science Stars”: Ed Gates, Helen Lockhart, Tim Oyer, Maryanne Trevisan, Michael Twomey and Patrick Waller.
The LMG Life Sciences guide is based on nearly 1,000 interviews and surveys completed by partners active in the market, interviews with clients and leading lawyers, and review of public information. View the complete 2018 rankings.
Here's what LMG Life Sciences had to say about the firm:
Wolf Greenfield & Sacks is a Boston-based IP boutique specializing in patent counseling and strategy for clients in a number of technical areas in the life sciences field. A peer says the firm is a "reliable heavyweight in patent prosecution," an area the firm receives top ranking. A client notes the firm's patent professionals deliver "excellent responsiveness and knowledge of the relevant business and technology space." In addition to the firm's strength in non-contentious patent matters, the group also has significant expertise handling post-grant proceedings at the Patent Office.President and managing partner Timothy Oyer specializes in patent procurement, portfolio strategy, opinions, licensing agreements, and other areas. He currently leads a team with Patrick RH Waller advising Oxford Nanopore on its patent portfolio related to diagnostic testing and germ monitoring. Edward Gates, deemed a "brilliant attorney" by a peer, has extensive experience counseling clients in the pharmaceutical and biotechnology areas on licensing and patent matters. Maryanne Trevisan provides clients with deep prosecution expertise in a number of advanced scientific areas, including cell biology and cancer therapies.Biotechnology group chair Helen Lockhart is a new member of the stars list this year for her expert guidance in IP matters for sophisticated life sciences clients. She currently acts as patent advisor to CRISPR Therapeutics, handling prosecution and strategy for the company's portfolio related to the groundbreaking technology CRISPR-Cas9.
The LMG Life Sciences guide is based on nearly 1,000 interviews and surveys completed by partners active in the market, interviews with clients and leading lawyers, and review of public information. View the complete 2018 rankings.